PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer
New England Journal of Medicine · 30.07.2026 · 395 (5) · 427-439
DOI: 10.1056/nejmoa2604126 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 30.07.2026. Verfasst von Neeraj Agarwal und 18 weiteren Autor:innen. Beteiligte Einrichtung: Huntsman Cancer Institute, University of Utah, Salt Lake City. Hauptthemen laut MEDLINE: Androgen Antagonists, Antineoplastic Combined Chemotherapy Protocols, Poly(ADP-ribose) Polymerase Inhibitors, Prostatic Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Pfizer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Huntsman Cancer Institute, University of Utah, Salt Lake City.
- National Cancer Center Hospital East, Chiba, Japan.
- Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
- Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal.
- Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona.
- Hunan Cancer Hospital, Changsha, China.
ORCID-Profile: Christof Vulsteke
Förderung
- Pfizer
Zitieren
APA
Agarwal, N., Matsubara, N., Azad, A. A., Saad, F., Mateo, J., Jiang, S., Ye, D., Voog, E., Shore, N. D., Çil, T., Vulsteke, C., Chung, H. J., Zschäbitz, S., Laird, A. D., Zhang, X., Nandoskar, P., Chetcuti, S. F., Wang, F., & Fizazi, K. (2026). PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer. New England Journal of Medicine, 395(5), 427-439. https://doi.org/10.1056/nejmoa2604126
Vancouver
Agarwal N, Matsubara N, Azad AA, Saad F, Mateo J, Jiang S, et al. PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer. New England Journal of Medicine. 2026;395(5):427-439. doi:10.1056/nejmoa2604126
BibTeX
@article{Agarwal2026,
author = {Agarwal, Neeraj and Matsubara, Nobuaki and Azad, Arun A and Saad, Fred and Mateo, Joaquin and Jiang, Shusuan and Ye, Dingwei and Voog, Eric and Shore, Neal D and Çil, Timuçin and Vulsteke, Christof and Chung, Hsiao-Jen and Zschäbitz, Stefanie and Laird, A Douglas and Zhang, Xiaoxi and Nandoskar, Prachi and Chetcuti, Sarah Fenech and Wang, Fong and Fizazi, Karim},
title = {PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {5},
pages = {427--439},
doi = {10.1056/nejmoa2604126}
}
EUVIMED